BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2645947)

  • 1. Indications for marrow transplantation in chronic myelogenous leukemia.
    Thomas ED; Clift RA
    Blood; 1989 Mar; 73(4):861-4. PubMed ID: 2645947
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow transplantation from unrelated donors in chronic myelogenous leukemia.
    Ehninger G; Klingebiel T; Schuler U; Einsele H; Schmidt H; Weiss B; Müller CA; Goldmann SF; Grosse-Wilde H; Niethammer D
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):49-50. PubMed ID: 8235708
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone marrow transplantation for chronic myelogenous leukemia using unrelated donors: the experience at Huddinge Hospital.
    Aschan J; Ringdén O; Ljungman P; Hägglund H; Klaesson S; Dalianis T; Remberger M
    Transplant Proc; 1995 Dec; 27(6):3531-2. PubMed ID: 8540086
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia.
    Hessner MJ; Endean DJ; Casper JT; Horowitz MM; Keever-Taylor CA; Roth M; Flomenberg N; Drobyski WR
    Blood; 1995 Nov; 86(10):3987-96. PubMed ID: 7579370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-2 for prevention of graft-versus-host disease after haploidentical marrow transplantation.
    Przepiorka D; Ippoliti C; Koberda J; Chan KW; Khouri IF; Fischer HE; Huh YO; Escudier SM; Seong D; Davis M
    Transplantation; 1994 Oct; 58(7):858-60. PubMed ID: 7940725
    [No Abstract]   [Full Text] [Related]  

  • 7. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone marrow transplantation in chronic myeloid leukemia].
    Hansz J
    Acta Haematol Pol; 1992; 23(2 Suppl 1):38-48. PubMed ID: 1488871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective.
    Enright H; Davies SM; DeFor T; Shu X; Weisdorf D; Miller W; Ramsay NK; Arthur D; Verfaillie C; Miller J; Kersey J; McGlave P
    Blood; 1996 Jul; 88(2):714-20. PubMed ID: 8695820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight loss, skin rash, and cough following bone marrow transplantation for chronic myelogenous leukemia.
    Witherspoon RP; McGlave P; Campbell JB; Sigley T; Rolston KV
    Cancer Pract; 1998; 6(4):202-5. PubMed ID: 9767331
    [No Abstract]   [Full Text] [Related]  

  • 11. Graft-versus-leukemia: no longer an epiphenomenon.
    Antin JH
    Blood; 1993 Oct; 82(8):2273-7. PubMed ID: 8400279
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation.
    Gratwohl A; Hermans J; Apperley J; Arcese W; Bacigalupo A; Bandini G; di Bartolomeo P; Boogaerts M; Bosi A; Carreras E
    Blood; 1995 Jul; 86(2):813-8. PubMed ID: 7606012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
    Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
    N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic graft-versus-host disease and seizure.
    Azuno Y; Yaga K; Kaneko T; Kaku K; Oka Y
    Blood; 1998 Apr; 91(7):2626-8. PubMed ID: 9516171
    [No Abstract]   [Full Text] [Related]  

  • 16. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation.
    Weisdorf DJ; Anasetti C; Antin JH; Kernan NA; Kollman C; Snyder D; Petersdorf E; Nelson G; McGlave P
    Blood; 2002 Mar; 99(6):1971-7. PubMed ID: 11877268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society.
    Espérou H; Boiron JM; Cayuela JM; Blanchet O; Kuentz M; Jouet JP; Milpied N; Cahn JY; Faucher C; Bourhis JH; Michallet M; Tanguy ML; Vernant JP; Gabert J; Bordigoni P; Ifrah N; Baruchel A; Dombret H;
    Bone Marrow Transplant; 2003 May; 31(10):909-18. PubMed ID: 12748668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern management of chronic myelogenous leukemia (CML).
    Feldman EJ; Arlin ZA
    Cancer Invest; 1988; 6(6):737-42. PubMed ID: 3072996
    [No Abstract]   [Full Text] [Related]  

  • 19. Matched and mismatched unrelated donor bone marrow transplantation for juvenile chronic myeloid leukaemia.
    Chown SR; Potter MN; Cornish J; Goulden P; Goulden N; Pamphilon D; Steward CG; Oakhill AO
    Br J Haematol; 1996 Jun; 93(3):674-6. PubMed ID: 8652391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of dasatinib in a chronic myeloid leukemia patient with disease molecular relapse and chronic GVHD after haploidentical BMT: an immunomodulatory effect?
    Breccia M; Cannella L; Stefanizzi C; Carotti A; Santopietro M; Alimena G
    Bone Marrow Transplant; 2009 Sep; 44(5):331-2. PubMed ID: 19219075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.